29 related articles for article (PubMed ID: 8725734)
1. Effect of aprotinin on the red cell immunity in cardiopulmonary bypass.
Luo J; Huang Y; Lan H
J Tongji Med Univ; 1998; 18(2):97-100. PubMed ID: 10806834
[TBL] [Abstract][Full Text] [Related]
2. Retrospective aprotinin cardiac surgical studies and their limitations: time for a prospective randomized clinical trial.
Erdoes G; Koster A; Levy JH
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38310331
[No Abstract] [Full Text] [Related]
3. The hemostatic defect of cardiopulmonary bypass.
Linden MD
J Thromb Thrombolysis; 2003 Dec; 16(3):129-47. PubMed ID: 15087599
[TBL] [Abstract][Full Text] [Related]
4. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.
Peters DC; Noble S
Drugs; 1999 Feb; 57(2):233-60. PubMed ID: 10188764
[TBL] [Abstract][Full Text] [Related]
5. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
6. Platelet dysfunction after normothermic cardiopulmonary bypass in children: effect of high-dose aprotinin.
Flaujac C; Pouard P; Boutouyrie P; Emmerich J; Bachelot-Loza C; Lasne D
Thromb Haemost; 2007 Aug; 98(2):385-91. PubMed ID: 17721621
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
8. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
9. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Thromb Haemost; 1996 May; 75(5):844-8. PubMed ID: 8725734
[TBL] [Abstract][Full Text] [Related]
11. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
Mössinger H; Dietrich W
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin in perspective.
Westaby S
Ann Thorac Surg; 1993 Apr; 55(4):1033-41. PubMed ID: 7682054
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
